Literature DB >> 25773347

Guidance on patient consultation. Current evidence for prostate-specific antigen screening in healthy men and treatment options for men with proven localised prostate cancer.

Giovannalberto Pini1, Justin Collins, Pirus Ghadjar, Peter Wiklund.   

Abstract

The main objective of this review is to summarise, for primary and secondary care doctors, the management options and current supporting evidence for clinically localised prostate cancer. We review all aspects of management including current guidelines on early cancer detection and the importance of informed consent on PSA-based screening and assess the most common treatment options and the evidence for managing patients with low-, medium-, and high-risk disease.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25773347     DOI： 10.1007/s11934-015-0502-1

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  82 in total

Review 1.  Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy.

Authors:  Vincenzo Ficarra; Giacomo Novara; Thomas E Ahlering; Anthony Costello; James A Eastham; Markus Graefen; Giorgio Guazzoni; Mani Menon; Alexandre Mottrie; Vipul R Patel; Henk Van der Poel; Raymond C Rosen; Ashutosh K Tewari; Timothy G Wilson; Filiberto Zattoni; Francesco Montorsi
Journal:  Eur Urol       Date:  2012-06-01       Impact factor: 20.096

2.  Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study.

Authors:  Jindong Ji; Hexing Yuan; Liangliang Wang; Jianquan Hou
Journal:  J Surg Res       Date:  2012-07-17       Impact factor: 2.192

Review 3.  Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy.

Authors:  Vincenzo Ficarra; Giacomo Novara; Raymond C Rosen; Walter Artibani; Peter R Carroll; Anthony Costello; Mani Menon; Francesco Montorsi; Vipul R Patel; Jens-Uwe Stolzenburg; Henk Van der Poel; Timothy G Wilson; Filiberto Zattoni; Alexandre Mottrie
Journal:  Eur Urol       Date:  2012-06-01       Impact factor: 20.096

Review 4.  Genetic analysis of the principal genes related to prostate cancer: a review.

Authors:  Maria Jesus Alvarez-Cubero; Maria Saiz; Luis Javier Martinez-Gonzalez; Juan Carlos Alvarez; Jose Antonio Lorente; Jose Manuel Cozar
Journal:  Urol Oncol       Date:  2012-11-07       Impact factor: 3.498

5.  Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial.

Authors:  Michel Bolla; Laurence Collette; Léo Blank; Padraig Warde; Jean Bernard Dubois; René-Olivier Mirimanoff; Guy Storme; Jacques Bernier; Abraham Kuten; Cora Sternberg; Johan Mattelaer; José Lopez Torecilla; J Rafael Pfeffer; Carmel Lino Cutajar; Alfredo Zurlo; Marianne Pierart
Journal:  Lancet       Date:  2002-07-13       Impact factor: 79.321

6.  Transition zone and anterior stromal prostate cancers: zone of origin and intraprostatic patterns of spread at histopathology.

Authors:  Sébastien Bouyé; Eric Potiron; Philippe Puech; Xavier Leroy; Laurent Lemaitre; Arnauld Villers
Journal:  Prostate       Date:  2009-01-01       Impact factor: 4.104

7.  Long-term treatment sequelae after external beam irradiation with or without hormonal manipulation for adenocarcinoma of the prostate: analysis of radiation therapy oncology group studies 85-31, 86-10, and 92-02.

Authors:  Colleen A Lawton; Kyoungwha Bae; Miljenko Pilepich; Gerald Hanks; William Shipley
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-09-19       Impact factor: 7.038

8.  Natural history of early, localized prostate cancer.

Authors:  Jan-Erik Johansson; Ove Andrén; Swen-Olof Andersson; Paul W Dickman; Lars Holmberg; Anders Magnuson; Hans-Olov Adami
Journal:  JAMA       Date:  2004-06-09       Impact factor: 56.272

Review 9.  The role of robot-assisted radical prostatectomy and pelvic lymph node dissection in the management of high-risk prostate cancer: a systematic review.

Authors:  Bertram Yuh; Walter Artibani; Axel Heidenreich; Simon Kimm; Mani Menon; Giacomo Novara; Ashutosh Tewari; Karim Touijer; Timothy Wilson; Kevin C Zorn; Scott E Eggener
Journal:  Eur Urol       Date:  2013-05-18       Impact factor: 20.096

10.  Combined androgen deprivation therapy and radiation therapy for locally advanced prostate cancer: a randomised, phase 3 trial.

Authors:  Padraig Warde; Malcolm Mason; Keyue Ding; Peter Kirkbride; Michael Brundage; Richard Cowan; Mary Gospodarowicz; Karen Sanders; Edmund Kostashuk; Greg Swanson; Jim Barber; Andrea Hiltz; Mahesh K B Parmar; Jinka Sathya; John Anderson; Charles Hayter; John Hetherington; Matthew R Sydes; Wendy Parulekar
Journal:  Lancet       Date:  2011-11-02       Impact factor: 79.321
View more
  2 in total

Review 1.  What's new in screening in 2015?

Authors:  Sigrid V Carlsson; Monique J Roobol
Journal:  Curr Opin Urol       Date:  2016-09       Impact factor: 2.309

2.  Development of a novel five-gene immune-related risk model for the prognosis evaluation of prostate adenocarcinoma patients.

Authors:  Hongjun Fei; Xiongming Chen
Journal:  Am J Cancer Res       Date:  2022-05-15       Impact factor: 5.942
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.